The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Russia cancer vaccine could receive approval by August allowing treatment to begin the head of the Gamaleya Research ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The ICMR has initiated the process of development of an ingenious human vaccine candidate against highly-pathogenic avian ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.